TargetPeroxisomal N(1)-acetyl-spermine/spermidine oxidase(Mus musculus)
Merrell Dow Research Institute
Curated by ChEMBL
Merrell Dow Research Institute
Curated by ChEMBL
Affinity DataKi: 1.70E+3nMAssay Description:Tested for in vitro binding affinity against polyamine oxidase after intraperitoneal administration in the rat liverMore data for this Ligand-Target Pair
TargetPeroxisomal N(1)-acetyl-spermine/spermidine oxidase(Mus musculus)
Merrell Dow Research Institute
Curated by ChEMBL
Merrell Dow Research Institute
Curated by ChEMBL
Affinity DataKi: 2.50E+3nMAssay Description:Tested for in vitro binding affinity against polyamine oxidase after intraperitoneal administration in the rat liverMore data for this Ligand-Target Pair
TargetPeroxisomal N(1)-acetyl-spermine/spermidine oxidase(Mus musculus)
Merrell Dow Research Institute
Curated by ChEMBL
Merrell Dow Research Institute
Curated by ChEMBL
Affinity DataKi: 3.00E+3nMAssay Description:Tested for in vitro binding affinity against polyamine oxidase after intraperitoneal administration in the rat liverMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometryMore data for this Ligand-Target Pair
TargetcAMP-dependent protein kinase catalytic subunit beta(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of PKA activity using neurogranin as a substrate in presence of 50 uM ATP by mass spectrometryMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 95nMAssay Description:Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometryMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.69E+3nMAssay Description:Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometryMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.81E+3nMAssay Description:Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometryMore data for this Ligand-Target Pair
TargetProtein kinase C alpha type(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.07E+3nMAssay Description:Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometryMore data for this Ligand-Target Pair
TargetcAMP-dependent protein kinase catalytic subunit beta(Homo sapiens (Human))
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Procter & Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.36E+4nMAssay Description:Inhibition of PKA activity using neurogranin as a substrate in presence of 50 uM ATP by mass spectrometryMore data for this Ligand-Target Pair